Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 50, 2021 - Issue 6
171
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Analysis of the Clinical Efficacy of Dendritic Cell –cytokine Induced Killer Cell-based Adoptive Immunotherapy for Colorectal Cancer

, , , , &

References

  • Chen CL, Pan QZ, Weng DS, Xie CM, Zhao JJ, Chen MS, Peng RQ, Li DD, Wang Y, Tang Y, et al. 2018 Jan 10. Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors. Oncoimmunology. 7(4):e1417721. doi:https://doi.org/10.1080/2162402X.2017.1417721.
  • Chen F, Yang M, Song Q, Wu J, Wang X, Zhou X, Yuan Y, Song Y, Jiang N, Zhao Y, et al. 2017. Enhanced antitumor effects and improved immune status of dendritic cell and cytokine induced killer cell infusion in advanced cancer patients. Mol Clin Oncol. 7:903–10.
  • Gao D, Li C, Xie X, Zhao P, Wei X, Sun W, Liu HC, Alexandrou AT, Jones J, Zhao R, et al. 2014. Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients. PLoS One. 9:e93886.
  • Greene JM, Schneble EJ, Jackson DO, Hale DF, Vreeland TJ, Flores M, Martin J, Herbert GS, Hardin MO, Yu X, et al. 2016. A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2. Cancer Immunol Immunother. 65(4):383–92. doi:https://doi.org/10.1007/s00262-016-1809-6.
  • Han L, Shang YM, Song YP, Gao QL. 2016. Biological character of retronectin activated cytokine- induced killer cells. J Immunol Res. 5706814. doi:https://doi.org/10.1155/2016/5706814
  • Hontscha C, Borck Y, Zhou H, Messmer D, Schmidt-Wolf IG. 2011. Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol. 137(2):305–10. doi:https://doi.org/10.1007/s00432-010-0887-7
  • Jiang N, Qiao G, Wang X, Morse MA, Gwin WR, Zhou L, Song Y, Zhao Y, Chen F, Zhou X, et al. 2017. Dendritic cell/cytokine-induced killer cell immunotherapy combined with S-1 in patients with advanced pancreatic cancer: a prospective study. Clin Cancer Res. 23(17):5066–73. doi:https://doi.org/10.1158/1078-0432.CCR-17-0492.
  • Kohnepoushi C, Nejati V, Delirezh N, Biparva P. 2019 Nov. Poly lactic-co-Glycolic acid nanoparticles containing human gastric tumor lysatesas antigen delivery vehicles for dendritic cell-based antitumor immunotherapy. Immunol Invest. 48(8):794–808. doi:https://doi.org/10.1080/08820139.
  • Lan XP, Chen YG, Wang Z, Yuan CW, Wang GG, Lu GL, Mao SW, Jin XB, Xia QH. 2015. Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients. J Zhejiang Univ-Sci B (Biomed & Biotechnol). 16:743–56.
  • Lia C, Zhao DZY, Guo Q, Sun W, Li L, Gao D, Zhao P. 2019 Dec 3. Dendritic cells therapy with cytokine-induced killer cells and activated cytotoxic T cells attenuated Th2 bias immune response. Immunol Invest. 1–13. doi:https://doi.org/10.1080/08820139.2019.1696360.
  • Lin T, Song C, Chuo DY, Zhang H, Zhao J. 2016. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study. Tumour Biol. 37:4367–72.
  • Liu Y, Zheng Z, Zhang Q, Zhou X, Feng Y, Yan A. 2017. FOLFOX regimen plus dendritic cells–cytokine induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis. Onco Targets Ther. 10:2621–33.
  • Song D, Yang XL, Feng HJ, Han YP, Liu JY, Zhang JP. 2012. Clinical efficacy of dendritic cell cytokine-induced killer cells combined with chemotherapy for patients with gastroenteric tumor. Chin J Cancer Biother. 39:497–501.
  • Song D, Yang XL, Yang XJ, Feng HJ, Zhang JP. 2018. Clinical efficacy of DC-CIK immunotherapy in treatment of advanced pancreatic adenocarcinoma. Chin J Cancer Biother. 25:401–06.
  • Wang Y, Xu Z, Zhou F, Sun Y, Chen J, Li L, Jin H, Qian Q. 2015. The combination of dendritic cellscytotoxic T lymphocytes/cytokine-induced killer (DC- CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors. Exp Hematol Oncol. 4:32.
  • Wang ZX, Cao JX, Wang M, Li D, Cui YX, Zhang XY, Liu JL, Li JL. 2014. Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis. Cytotherapy. 16:934–45.
  • Zhang S, Jiang SJ, Zhang CQ, Wang HM, Bai CX. 2005. Antitumour activities of cytokine-induced killer cells and dendritic cells in vitro and in vivo. Chin Med J. 118(15):1308–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.